001     137515
005     20240321220250.0
024 7 _ |a 10.3389/fnagi.2014.00161
|2 doi
024 7 _ |a pmid:25071568
|2 pmid
024 7 _ |a pmc:PMC4088338
|2 pmc
037 _ _ |a DZNE-2020-03837
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Heinzel, Sebastian
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a A neurodegenerative vascular burden index and the impact on cognition.
260 _ _ |a Lausanne
|c 2014
|b Frontiers Research Foundation
264 _ 1 |3 online
|2 Crossref
|b Frontiers Media SA
|c 2014-07-09
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1601986946_12125
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a A wide range of vascular burden factors has been identified to impact vascular function and structure as indicated by carotid intima-media thickness (IMT). On the basis of their impact on IMT, vascular factors may be selected and clustered in a vascular burden index (VBI). Since many vascular factors increase the risk of Alzheimer's disease (AD), a multifactorial neurodegenerative VBI may be related to early pathological processes in AD and cognitive decline in its preclinical stages. We investigated an elderly cohort at risk for neurodegeneration (TREND study, n = 1102) for the multifactorial influence of vascular burden factors on IMT measured by ultrasound. To create a VBI for this cohort, vascular factors and their definitions (considering medical history, medication, and/or blood marker data) were selected based on their statistical effects on IMT in multiple regressions including age and sex. The impact of the VBI on cognitive performance was assessed using the Trail-Making Test (TMT) and the consortium to establish a registry for Alzheimer's disease (CERAD) neuropsychological battery. IMT was significantly predicted by age (standardized β = 0.26), sex (0.09; males > females) and the factors included in the VBI: obesity (0.18), hypertension (0.14), smoking (0.08), diabetes (0.07), and atherosclerosis (0.05), whereas other cardiovascular diseases or hypercholesterolemia were not significant. Individuals with 2 or more VBI factors compared to individuals without had an odds ratio of 3.17 regarding overly increased IMT ( ≥ 1.0 mm). The VBI showed an impact on executive control [log(TMT B-A), p = 0.047] and a trend toward decreased global cognitive function (CERAD total score, p = 0.057) independent of age, sex, and education. A VBI established on the basis of IMT may help to identify individuals with overly increased vascular burden linked to decreased cognitive function indicating neurodegenerative processes. The longitudinal study of this risk cohort will reveal the value of the VBI as prodromal marker for cognitive decline and AD.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Liepelt-Scarfone, Inga
|0 P:(DE-2719)2109499
|b 1
|u dzne
700 1 _ |a Roeben, Benjamin
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Nasi-Kordhishti, Isabella
|b 3
700 1 _ |a Suenkel, Ulrike
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Wurster, Isabel
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Brockmann, Kathrin
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fritsche, Andreas
|b 7
700 1 _ |a Niebler, Raphael
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Metzger, Florian G
|b 9
700 1 _ |a Eschweiler, Gerhard W
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Fallgatter, Andreas J
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Maetzler, Walter
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Berg, Daniela
|0 P:(DE-2719)2000059
|b 13
|e Last author
|u dzne
773 1 8 |a 10.3389/fnagi.2014.00161
|b : Frontiers Media SA, 2014-07-09
|3 journal-article
|2 Crossref
|t Frontiers in Aging Neuroscience
|v 6
|y 2014
|x 1663-4365
773 _ _ |a 10.3389/fnagi.2014.00161
|g Vol. 6
|0 PERI:(DE-600)2558898-9
|q 6
|p 161
|t Frontiers in aging neuroscience
|v 6
|y 2014
|x 1663-4365
856 4 _ |u https://www.frontiersin.org/articles/10.3389/fnagi.2014.00161/full
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088338
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/137515/files/6044.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:137515
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2109499
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2000059
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
914 1 _ |y 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT AGING NEUROSCI : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser 1
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg
|l Parkinson's Disease Genetics AG Berg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000055
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1093/eurheartj/ehp496
|2 Crossref
|o 10.1093/eurheartj/ehp496
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1353-8020(11)70061-X
|2 Crossref
|o 10.1016/S1353-8020(11)70061-X
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.CIR.96.5.1432
|2 Crossref
|o 10.1161/01.CIR.96.5.1432
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.ATV.13.1.64
|2 Crossref
|o 10.1161/01.ATV.13.1.64
999 C 5 |9 -- missing cx lookup --
|a 10.1016/1047-2797(96)00001-4
|2 Crossref
|o 10.1016/1047-2797(96)00001-4
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nprot.2006.390
|2 Crossref
|o 10.1038/nprot.2006.390
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0197-4580(99)00110-4
|2 Crossref
|o 10.1016/S0197-4580(99)00110-4
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2010-1240
|2 Crossref
|o 10.3233/JAD-2010-1240
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000167607.63000.38
|2 Crossref
|o 10.1212/01.wnl.0000167607.63000.38
999 C 5 |9 -- missing cx lookup --
|a 10.1097/WAD.0b013e3181b4f736
|2 Crossref
|o 10.1097/WAD.0b013e3181b4f736
999 C 5 |9 -- missing cx lookup --
|a 10.1002/1097-4679(198707)43:4402::AID-JCLP22704304113.0.CO;2-E
|2 Crossref
|o 10.1002/1097-4679(198707)43:4402::AID-JCLP22704304113.0.CO;2-E
999 C 5 |9 -- missing cx lookup --
|a 10.1161/CIRCULATIONAHA.107.699579
|2 Crossref
|o 10.1161/CIRCULATIONAHA.107.699579
999 C 5 |9 -- missing cx lookup --
|a 10.1155/2012/367516
|2 Crossref
|o 10.1155/2012/367516
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2012-120793
|2 Crossref
|o 10.3233/JAD-2012-120793
999 C 5 |9 -- missing cx lookup --
|a 10.1001/jama.2012.9630
|2 Crossref
|o 10.1001/jama.2012.9630
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S1355617710000822
|2 Crossref
|o 10.1017/S1355617710000822
999 C 5 |9 -- missing cx lookup --
|a 10.1093/eurheartj/ehs380
|2 Crossref
|o 10.1093/eurheartj/ehs380
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.STR.25.1.66
|2 Crossref
|o 10.1161/01.STR.25.1.66
999 C 5 |9 -- missing cx lookup --
|a 10.1111/ene.12382
|2 Crossref
|o 10.1111/ene.12382
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2012.05.021
|2 Crossref
|o 10.1016/j.neurobiolaging.2012.05.021
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0027831
|2 Crossref
|o 10.1371/journal.pone.0027831
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.60.12.1707
|2 Crossref
|o 10.1001/archneur.60.12.1707
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1468-1331.2010.03040.x
|2 Crossref
|o 10.1111/j.1468-1331.2010.03040.x
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000435301.64776.37
|2 Crossref
|o 10.1212/01.wnl.0000435301.64776.37
999 C 5 |9 -- missing cx lookup --
|a 10.2337/dc09-1231
|2 Crossref
|o 10.2337/dc09-1231
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.62.10.1556
|2 Crossref
|o 10.1001/archneur.62.10.1556
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1600-0404.2006.00685.x
|2 Crossref
|o 10.1111/j.1600-0404.2006.00685.x
999 C 5 |9 -- missing cx lookup --
|a 10.1038/oby.2006.196
|2 Crossref
|o 10.1038/oby.2006.196
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrneurol.2013.107
|2 Crossref
|o 10.1038/nrneurol.2013.107
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e318217e7a4
|2 Crossref
|o 10.1212/WNL.0b013e318217e7a4
999 C 5 |y 2014
|2 Crossref
|t Alzheimers Dement.
|o Lim Alzheimers Dement. 2014
999 C 5 |9 -- missing cx lookup --
|a 10.1161/CIRCULATIONAHA.106.628875
|2 Crossref
|o 10.1161/CIRCULATIONAHA.106.628875
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.STR.0000136720.21095.f3
|2 Crossref
|o 10.1161/01.STR.0000136720.21095.f3
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2012-120625
|2 Crossref
|o 10.3233/JAD-2012-120625
999 C 5 |9 -- missing cx lookup --
|a 10.1093/eurheartj/ehm236
|2 Crossref
|o 10.1093/eurheartj/ehm236
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000435558.98447.17
|2 Crossref
|o 10.1212/01.wnl.0000435558.98447.17
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.39.9.1159
|2 Crossref
|o 10.1212/WNL.39.9.1159
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0067809
|2 Crossref
|o 10.1371/journal.pone.0067809
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.STR.27.2.224
|2 Crossref
|o 10.1161/01.STR.27.2.224
999 C 5 |9 -- missing cx lookup --
|a 10.1136/bmj.d124
|2 Crossref
|o 10.1136/bmj.d124
999 C 5 |9 -- missing cx lookup --
|a 10.1097/WAD.0b013e318187541c
|2 Crossref
|o 10.1097/WAD.0b013e318187541c
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.111.000745
|2 Crossref
|o 10.1161/STROKEAHA.111.000745
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1365-2796.1991.tb00336.x
|2 Crossref
|o 10.1111/j.1365-2796.1991.tb00336.x
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S1355617709090626
|2 Crossref
|o 10.1017/S1355617709090626
999 C 5 |9 -- missing cx lookup --
|a 10.3233/Jad-2012-120157
|2 Crossref
|o 10.3233/Jad-2012-120157
999 C 5 |9 -- missing cx lookup --
|a 10.1002/clc.4960270704
|2 Crossref
|o 10.1002/clc.4960270704
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000343145
|2 Crossref
|o 10.1159/000343145
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0002-9149(02)02660-7
|2 Crossref
|o 10.1016/S0002-9149(02)02660-7
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.atherosclerosis.2013.01.025
|2 Crossref
|o 10.1016/j.atherosclerosis.2013.01.025
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.STR.32.2.454
|2 Crossref
|o 10.1161/01.STR.32.2.454
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.49.3_Suppl_3.S11
|2 Crossref
|o 10.1212/WNL.49.3_Suppl_3.S11
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tins.2005.02.001
|2 Crossref
|o 10.1016/j.tins.2005.02.001
999 C 5 |9 -- missing cx lookup --
|a 10.1097/00004872-200201000-00013
|2 Crossref
|o 10.1097/00004872-200201000-00013


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21